Get Started in Minutes
How Abraxane Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Abraxane?
Abraxane is a chemotherapy medication currently available as a trademarked brand name. It is also available as a generic medication called paclitaxel. It is considered a systemic treatment used to treat metastatic cancer that has spread from one part of the body to another. Being a systemic treatment means that the medication travels through the bloodstream so that it can reach cells in other parts of the body, including cancer cells. Abraxane primarily works by blocking the action of proteins called microtubules, which are proteins that help cells divide. By doing this, it stops cancer cells from dividing and making new cells, and therefore blocks the growth of cancer cells.
Abraxane is available as an injectable solution that is administered intravenously by trained healthcare professionals at the doctor’s office, at clinics, or in hospitals. It is only available with a prescription written by your doctor.
What Is Abraxane Used To Treat?
Abraxane is used to treat a variety of cancers, such as metastatic breast cancer, metastatic pancreatic cancer, and advanced non-small cell lung cancer. More specifically, Abraxane is used for:
- Metastatic breast cancer:
Abraxane is used after there has been failure of combination chemotherapy or relapse within 6 months of adjuvant chemotherapy. Adjuvant therapy is defined as therapy given in addition to the primary or initial therapy to maximize the effectiveness of treatment. The prior therapy that failed should have included an anthracycline unless it was clinically contraindicated.
- Metastatic pancreatic cancer:
Abraxane is used as a first-line treatment in combination with another chemotherapy medication called gemcitabine.
- Advanced non-small cell lung cancer (NSCLC):
Abraxane is used as a first-line treatment in combination with another chemotherapy medication called carboplatin. For treatment of advanced non-small cell lung cancer with Abraxane, patients cannot be candidates for any type of curative surgery or radiation therapy.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Abraxane Side Effects
Prior to starting Abraxane, all patients must be thoroughly screened to ensure that this is the best course of treatment for their diagnosis.
It is important to note the following contraindications and safety warnings/precautions on the use of Abraxane.
- Abraxane cannot be taken if your white blood cell count is less than 1,500 cells/mm (neutropenia) as it can cause a serious infection that may lead to other complications.
- The medication should be avoided if you have had a severe allergic reaction (hypersensitivity) to Abraxane.
Safety Warnings and Precautions:
- Abraxane can cause myelosuppression which can lower your red blood cells, white blood cells, and platelets. Your CBC must be monitored and the dose may be withheld or reduced if needed. Signs and symptoms of myelosuppression include:
- Shortness of breath
- Sepsis can occur in patients with or without neutropenia who received Abraxane together with gemcitabine.
- Pneumonitis can occur with the use of Abraxane in combination with gemcitabine.
- Severe hypersensitivity reactions are possible. Do not re-challenge.
- Severe neuropathy may occur.
- Use in patients with hepatic impairment:
- Exposure and toxicity of Abraxane can be increased in patients with hepatic impairment.
- Close monitoring is required for patients with hepatic impairment for severe myelosuppression.
Common Side Effects:
- Sensory neuropathy
- Peripheral neuropathy
- Hair loss (alopecia)
- Decreased appetite
- Peripheral edema
- Abraxane can harm your unborn baby.
- Women of childbearing potential must avoid becoming pregnant while on treatment.
- Women must use effective birth control (contraception) during treatment for at least six months after the last dose of Abraxane.
- Men must not father a child and should use effective birth control (contraception) during treatment and for at least three months after their final dose of Abraxane.
Directions for Use
Abraxane will be given intravenously (IV) by trained healthcare professionals. Dosage is based on the type of diagnosis. Please see the following:
For metastatic breast cancer:
- The recommended dosage of Abraxane is 260 mg/m2 intravenously over 30 minutes every 3 weeks.
For pancreatic cancer:
- The recommended dosage of Abraxane is 125 mg/m2 intravenously over 30 to 40 minutes on days 1, 8, and 15 out of each 28-day cycle.
- Administer gemcitabine on days 1, 8, and 15 out of each 28-day cycle immediately after Abraxane.
For non-small cell lung cancer:
- The recommended dosage of Abraxane is 100 mg/m2 intravenously over 30 minutes on days 1, 8, and 15 out of each 21-day cycle.
- Administer carboplatin on day 1 out of each 21-day cycle immediately after Abraxane.
A dose may be reduced or discontinued based on severe hematologic, cutaneous, neurologic, or gastrointestinal toxicities.